MedPath

Family-Based Prevention Program for Childhood Anxiety

Not Applicable
Completed
Conditions
Anxiety Disorders
Registration Number
NCT00078728
Lead Sponsor
Johns Hopkins University
Brief Summary

This study will evaluate the effectiveness of a short-term family-based program for preventing anxiety disorders in at-risk children.

Detailed Description

Anxiety disorders are serious conditions that can negatively impact a person's overall functioning. This study will enroll mothers with anxiety disorders and their children to determine whether a brief family-based intervention will reduce childhood anxiety better than standard care.

Participants will be randomly assigned to either the family-based prevention program or to evaluation only for 8 weeks. Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety. Self- and parent-reports, diagnostic interviews, a computerized memory task, and a videotaped parent-child interaction task will be used to assess participants. Assessments will be conducted at study start and one week after intervention completion (Week 9). Follow-up visits will be conducted at 6 and 12 months after intervention completion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Mothers with a current, primary anxiety disorder
  • 7-12 year old children without an anxiety disorder
Exclusion Criteria
  • Mothers that do not have a current, primary anxiety disorder
  • 7-12 year old children with an anxiety disorder
  • 7-12 year old children that are currently receiving treatment for anxiety that could interfere with the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Children With Child Anxiety Diagnosis12 month

Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.

Child Anxiety Diagnoses12 months

The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Hopkins University School of Medicine

🇺🇸

Baltimore, Maryland, United States

Johns Hopkins University School of Medicine
🇺🇸Baltimore, Maryland, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.